-SEC Filing
Related Posts
Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What’s Going On?
Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S.
RBC Capital Maintains Outperform on Mercer Intl, Raises Price Target to $20
RBC Capital analyst Paul Quinn maintains Mercer Intl (NASDAQ:MERC) with a Outperform and raises the price target from $17 to $20.
Vaccinex Granted U.S. Patent #11572408: Treatment Of Cancer With A Semaphorin-4D Antibody In Combination With An Epigenetic Modulating Agent
https://www.scribd.com/document/624286709/VCNX-Patent